Decitabine induces IRF7-mediated immune responses in p53-mutated triple-negative breast cancer: a clinical and translational study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Decitabine induces IRF7-mediated immune responses in p53-mutated triple-negative breast cancer: a clinical and translational study

Published:2023-12-29 Issue: Volume: Page:
ISSN:2095-0217
Container-title:Frontiers of Medicine
language:en
Short-container-title:Front. Med.

Author:

Wang Haoyu,Wang Zhengyuan,Wang Zheng,Li Xiaoyang,Li Yuntong,Yan Ni,Wu Lili,Liang Ying,Wu Jiale,Song Huaxin,Qu Qing,Huang Jiahui,Chang Chunkang,Shen Kunwei,Chen Xiaosong,Lu Min

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11684-023-1016-8.pdf

Reference52 articles.

1. Tannock IF, Hickman JA. Limits to personalized cancer medicine. N Engl J Med 2016; 375(13): 1289–1294

2. Prasad V. Perspective: The precision-oncology illusion. Nature 2016; 537(7619): S63

3. Joerger AC, Fersht AR. The p53 pathway: origins, inactivation in cancer, and emerging therapeutic approaches. Annu Rev Biochem 2016; 85(1): 375–404

4. Muller PAJ, Vousden KH. Mutant p53 in cancer: new functions and therapeutic opportunities. Cancer Cell 2014; 25(3): 304–317

5. Muller PAJ, Vousden KH. p53 mutations in cancer. Nat Cell Biol 2013; 15(1): 2–8

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP